A focused look at how research commercialization can turn lab work into a fundable startup.
Autumn on the Air keeps its attention on research commercialization and the messy step between a university lab and something that can work in the market.

Where research learns to move.
AUTM on the Air is a focused interview show about research commercialization, tech transfer, and university-born innovation. Its conversations stay close to the operational questions: when to form a startup, how IP gets funded, why partnerships hold, and what blocks adoption.
PRESS PLAY
AUTM on the Air is a professional interview show about the route from academic research to usable impact. Its center of gravity is technology transfer, but the conversations reach into venture creation, licensing, biotech, healthcare AI, federal policy, and industry partnerships. The show is most useful when it treats commercialization as a chain of practical choices. A promising discovery is only the start. Recent episodes ask when a university technology should become a company, how founders should be paired with deep tech, and why early involvement can change the strength and scope of an IP strategy. Other conversations widen the frame. Industry guests describe what companies need from academic partners, how research relationships develop over time, and why useful products often come from persistent collaboration rather than flashy invention. The medical research episodes give the show a particularly concrete sense of stakes. Discussions of pediatric neuroblastoma therapy, broad-spectrum antiviral funding, and validated healthcare AI keep the focus on translation, evidence, adoption, and scale. The show also pays attention to Washington, D.C., where research policy, intellectual property, and university innovation meet federal decision-making. Its guests tend to be people who work inside the system: licensing managers, venture builders, commercialization leaders, healthcare innovation operators, policy advocates, and company-side partnership leads. The questions are structured and context-heavy. They usually begin with the institutional problem before asking the guest to explain how a decision works in practice. That gives the episodes a measured, analytical rhythm. AUTM on the Air does not flatten the terminology for a general audience, but it usually places technical language inside a clear operational problem. PCT filings, startup de-risking, founder roles, AI validation, and commercialization pathways are discussed as tools with consequences. The show is therefore less about inspiration than judgment. It helps listeners understand what has to line up before research can become a product, a company, a policy priority, or a therapy. For people working near universities, startups, funders, or research-intensive companies, it offers a steady look at the institutions behind innovation.
Made for: Designed for tech transfer professionals, university innovators, licensing teams, research administrators, venture builders, and industry partners who already understand the commercialization landscape. It also suits biotech, medtech, and healthcare innovation listeners who want practical context around translation and adoption.
What sets it apart: The show stands out by staying inside the real mechanics of commercialization: IP timing, founder fit, partnership structure, funding stages, policy pressure, and implementation barriers. It treats impact as institutional work, not just a story of invention.
AUTM on the AIR is the weekly podcast that brings you conversations about the impact of research commercialization and the people who make it happen. Join us for interviews with patent and licensing professionals, innovators, entrepreneurs, and tech transfer leaders on the issues and trends that matter most.
Based on 5 episodes we listened to · September 2026
AUTM on the Air reveals the negotiations, legal choices and human pressures that shape a university discovery's route into public use.
AUTM on the Air keeps its attention on the difficult middle between university research and public use. Lisa Mueller's interviews follow discoveries through patent decisions, licensing offices, startup formation, funding and industry partnerships.
A gene patent reaches the Supreme Court, and suddenly your innovation strategy has case law.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A focused look at how research commercialization can turn lab work into a fundable startup.
Autumn on the Air keeps its attention on research commercialization and the messy step between a university lab and something that can work in the market.
A practical look at how research commercialization turns a discovery into a company.
Autumn on the Air keeps its focus on a practical problem: when a discovery should turn into a company, and what happens between invention disclosure and a venture-backed startup.
A blunt look at the human cost of keeping tech transfer moving.
Autumn on the Air treats mental health in tech transfer as a systems problem, not a private one. The episode stays close to the pressures that shape the work: policy uncertainty, funding cuts, and the strain on tech transfer offices.
A practical look at how university commercialization depends on trust, alignment, and shared benefit.
The episode treats university commercialization as work, not branding. Todd Davey and Medisa Fosik discuss a comparative study of university IP commercialization across five global regions, and the discussion stays close to the conditions that actually move research forward:…
A measured look at the biotech patent disputes that helped define the field.
Jorge Goldstein frames the biotech patent fights with a steady, informed hand, moving through Myriad Genetics, GeneDx, and Rewinds to show how gene patents, antibody claims, and enablement disputes shape the field.



Clinical research, reduced to its practical signal.

Oncology evidence translated into clinical decisions.

Critical care evidence, carefully talked through.

Evidence translated into clinical next steps.
Marc Filerman, Chief Business Officer at Start2Group and a serial startup founder with MS and BS engineering degrees from MIT, explains to AUTM on the Air host Lisa Mueller what separates successful early-stage startups from those that fail.
Autumn on the Air asks when research should become a company.
This episode features an interview with Mark Fairey, Senior Licensing Manager at StemCell Technologies, discussing how to build strong, long-term industry-academic partnerships for research commercialization.
This episode explores the development of Danyelza (Naxidimab), a life-saving immunotherapy for pediatric neuroblastoma at Memorial Sloan Kettering Cancer Center, featuring interviews with key researchers and commercialization experts.
This episode explores how Brilliance is using AI and blockchain to create new models for IP ownership and investment, making intellectual property more accessible and investable.
An interview with David Chang about university-industry collaborations from the industry perspective.
This episode discusses the challenges of scaling AI in healthcare, featuring Adam Brickman from Vega Health.
Interview with Mike Waring about the mood in Washington D.C.
Interview with Michelle Derborough from the Michael J.
An interview with leaders from URI Innovations about their rebrand, Rise Up entrepreneurship training, and inaugural tech showcase.
This episode discusses the creation of a Technology Transfer Handbook through an innovative collaborative process called Book Sprints, featuring interviews with key contributors.
Interviews with leaders in technology transfer and research commercialization, discussing IP policies and innovation.
Interview with Steve Sosolka about the WIPO Autumn Knowledge and Technology Transfer Summit in Bangkok, discussing global challenges and opportunities in tech transfer.
Autumn on the Air continues its mental health and tech transfer series with a focused conversation about resilience.
Autumn on the Air turns to university commercialization.
Interview with Sam Tetlow, founder of The Grand Engine, about securing non-dilutive funding for life science and technology companies.
Interview with Michael Leon, author and mentor, discussing his career in space tourism, ocean exploration, and startup mentorship.
This episode features an interview with Jason Menzo, CEO of the Foundation Fighting Blindness, discussing his leadership, the organization's role as the world's largest private funder of research for blinding retinal diseases, and its impact including involvement in developing LuxTerm.
Autumn on the Air talks with Dr.
This episode examines the intersection of federal policy, scientific funding, and America's global leadership in innovation, featuring an interview with New York Times correspondent Kate Zernike.
This episode features an interview with Junji Nishihata, Senior Communications Advisor at McGill University, discussing how the McGill Innovation Fund transforms academic research into real-world impact through commercialization and entrepreneurship.
Interview with Millicent Milley-Pitts, CEO of Ocean Exchange, discussing ocean sustainability innovation and the blue economy.
Interview with Dr.
This episode features Dr.
Interview with Paul White, CEO of Hidden Disability Sunflower, about raising awareness for non-visible disabilities and promoting inclusion.
This episode explores how climate-focused technologies are developed, commercialized, and scaled, featuring an interview with Josh Dorfman, CEO of Planted, a company creating carbon-negative building materials.
This episode explores how Stargaze's AI-powered tool helps universities identify and monetize hidden opportunities in their research ecosystems to overcome funding challenges.
This episode features an interview with Dan Dardani, a tech transfer expert, discussing the complexities of software licensing, AI, and open source in research commercialization.
This episode features an interview with Dr.
This episode explores equity allocation in biotech startups, analyzing data from companies that went public between 2021 and 2023.
Interview with European patent attorney Rose Hughes discussing patent law, technology transfer, and her career journey.
Interview with innovation expert Nick Webb about the future of technology transfer and how universities can adapt to chaotic innovation.